Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study
Dan Yamin, Matan Yechezkel, Ronen Arbel, Tanya Beckenstein, Ruslan Sergienko, Hadar Duskin‐Bitan, Shlomit Yaron, Alon Peretz, Doron Netzer, Erez Shmueli
Topics & Concepts
Bivalent (engine)VaccinationBooster doseBooster (rocketry)Coronavirus disease 2019 (COVID-19)MedicineAdverse effectFamily medicineHealth carePediatricsVirologyInternal medicineInfectious disease (medical specialty)DiseaseVirusTiterChemistryEconomicsOrganic chemistryPhysicsEconomic growthMetalAstronomySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesHeparin-Induced Thrombocytopenia and Thrombosis